CDKN1B, cyclin dependent kinase inhibitor 1B, 1027

N. diseases: 454; N. variants: 20
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 Biomarker group BEFREE Differential roles of Hath1, MUC2 and P27Kip1 in relation with gamma-secretase inhibition in human colonic carcinomas: a translational study. 23409082 2013
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 Biomarker group BEFREE To investigate the role of cell cycle regulators in the pathogenesis and progression of human gastric cancer, the expression of cyclin D1, A, B1, p16(INK4a), p21(CPI1), p27(KIP1), p53, and pRb was investigated in 482 gastric carcinomas using immunohistochemistry in terms of histologic type, tumor invasion, size, location, and metastatic behavior. 20334896 2010
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 AlteredExpression group BEFREE Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways. 19855998 2009
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 AlteredExpression group BEFREE On the other hand, both Se forms decreased the expression of cyclin D1 and increased levels of P27Kip1 and c-Jun NH2-terminal kinase activation in a majority of the mammary carcinomas. 19276161 2009
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 Biomarker group BEFREE Indeed, genetic ablation of the p27(Kip1) or Rb genes accentuated Tag-induced tumorigenesis, with loss of Rb in particular broadly enhancing multiple parameters of tumorigenesis including the frequency and growth rates of premalignant lesions, of nascent solid tumors, and of invasive carcinomas. 16007165 2005
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 Biomarker group BEFREE A progressive significant increase in the levels of 8-OHdG and in the percentage of mean positive cells was observed from L-SIL (2.2%) to H-SIL (12.5%) to invasive carcinomas (25.2%). p27Kip1 and 8-OHdG expression displayed a significant inverse relationship. 14984940 2004
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 AlteredExpression group BEFREE Distinct altered patterns of p27Kip1 protein expression are found in a variety of human carcinomas, and p27Kip1 expression levels usually correlate directly with disease-free survival. 11042700 2000
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 Biomarker group BEFREE Although the short follow-up time (2-3 years) of the current series of patients does not allow the performance of survival analyses, the correlation of beta(1C) expression with tumor size, grade, and proliferative fraction and its alleged role as an upstream regulator of p27(kip1) make this integrin variant a likely novel prognostic parameter for invasive carcinomas of the breast. 10623664 2000
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 AlteredExpression group BEFREE Although genetic changes of p27/kip1 are extremely rare, in many human carcinomas p27 levels are reduced, correlate with histological malignancy, and are associated with poor prognosis. 10603039 1999
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 AlteredExpression group BEFREE Contrary to that, high levels of p27Kip1 are associated with poor overall survival in invasive cervical carcinomas of clinical stage IB. 9891436 1999
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 AlteredExpression group BEFREE Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein. 10078919 1999
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 AlteredExpression group BEFREE This study was undertaken to identify potential abnormalities of p27(Kip1) and cyclin D1 expression in extrahepatic bile duct carcinomas and to assess the prognostic significance of p27(Kip1) and cyclin D1 levels for patients with this disease. 10534337 1999
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 Biomarker group BEFREE In this study, we evaluated the prognostic value of p27Kip1 in a series of 96 superficial (pTa-1) human bladder carcinomas. 10397272 1999
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 AlteredExpression group BEFREE Lack of detectable expression of p27kip1 cyclin dependent kinase inhibitor has previously been correlated with high degree of malignancy in human breast, colorectal, gastric and small cell lung carcinomas. 10597239 1999
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 AlteredExpression group BEFREE In contrast to BPH, prostate carcinomas were found to contain abundant p27KIP1 mRNA but either high or low to undetectable levels of p27 protein. 9731735 1998
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.200 Biomarker group HPO